awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33822083-1FAE9608-61E9-42AB-AEF1-F60E694EDC6D
Q33822083-1FAE9608-61E9-42AB-AEF1-F60E694EDC6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33822083-1FAE9608-61E9-42AB-AEF1-F60E694EDC6D
Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program.
P2860
Q33822083-1FAE9608-61E9-42AB-AEF1-F60E694EDC6D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33822083-1FAE9608-61E9-42AB-AEF1-F60E694EDC6D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e3a8a61ad5559c7fe2f845af9e2f973cd4feb453
P2860
Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials.